Latest News about BMRN
Recent news which mentions BMRN
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
From Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
2 Under-the-Radar Biotech Picks to Buy For The Long Haul
December 24, 2021
From Motley Fool
This Favorable Sign Appears On Biomarin Pharmaceutical's Chart
November 25, 2021
Tickers
BMRN
From Benzinga
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
November 24, 2021
Tickers
BMRN
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
November 22, 2021
From Benzinga
Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday
November 20, 2021
Tickers
BMRN
From Motley Fool
From Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
From Benzinga
BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript
October 28, 2021
Tickers
BMRN
From Motley Fool
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
October 23, 2021
From Motley Fool
The Smartest Stocks to Buy With $250 Right Now
October 22, 2021
From Motley Fool
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.